NLRC4 and cancer: In the absence of side-by-side knock-out experiments of the different inflammasome components (i.e. NAIPs, NLRC4, ASC, Caspase-1) using corresponding littermate controls, it is difficult to unpick whether the effect of NAIPs in cancer is driven exclusively by non-inflammasome or inflammasome mechanisms, or a combination of the two.